Aeterna Zentaris GmbH

General information
Aeterna Zentaris GmbH
Weismüllerstrasse 50
60314 Frankfurt, Hessen
Germany

Contact person: Klaus Paulini, Chief Executive Officer
Company main phone: +49 (69) 426023228
Company main fax:  +49 (69) 426023444
Website:  https://www.aezsinc.com
Year founded:2002
Source of foundation:Subsidiary
Name of foundation source:Aeterna Zentaris, Inc.
Corporate description / mission:
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The development and research site is based in Germany.
State of ownership: Subsidiary
Headquarters: No
Categorization
Sector:
  • Biotechnology - Therapeutics and Diagnostics
Subsector:
  • Peptides
  • Small molecules
  • Vaccines
Primary therapeutic areas:
  • Endocrine, nutritional and metabolic diseases / endocrinology
Business model:
  • R&D
  • Subsidiary
Customer segments:
  • Hospitals
  • Large biotech & big pharma
  • Physicians / doctors
Summary Products / Services / Technologies
Number of Biotech Products
Pre-clinical:6
Phase III:1
On the market:1
Description of products:
Macimorelin
AEZS-150
© 2023 Biotechgate by Venture Valuation
X